Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alex Zisson currently holds 490,531 shares of Clarus Therapeutics Holdings, Inc. (CRXT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alex Zisson has been a net seller of CRXT stock. They have purchased $1.0M and sold $39.0M worth of shares.
Alex Zisson's most recent insider trade was on Sep 9, 2021, when they sold 490,531 shares at $0.00 per share.
Alex Zisson serves as Executive at Clarus Therapeutics Holdings, Inc. (CRXT). They have executed 16 insider transactions totaling $40.0M over their tenure at the company.
Alex Zisson holds the position of Executive at Clarus Therapeutics Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Alex Zisson has shown a selling trading pattern, with $1.0M in total purchases and $39.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Alex Zisson was on Jan 28, 2015, when they sold $38.8M worth of ASPX shares. This transaction involved 730,000 shares at $53.11 per share.
Alex Zisson currently owns 490,531 shares of Clarus Therapeutics Holdings, Inc. (CRXT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alex Zisson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alex Zisson has 16 Form 4 filings on record as an insider at Clarus Therapeutics Holdings, Inc..
Set alerts for Alex Zisson and 40,000+ other insiders.